Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate Complexes
- 13 May 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (13) , 3381-3387
- https://doi.org/10.1021/jm030640n
Abstract
Although progesterone, the natural ligand of the progesterone receptor (PR), has a hydrogen atom at the 17alpha position, other potent steroid agonists such as norethindrone and mometasone furoate have larger substituents at this position that are accommodated by the PR ligand binding pocket. Crystallographic analysis of PR ligand binding domain complexes clearly demonstrated that these moieties were accommodated by local shifts of the protein main chain and by adoption of alternative side chain rotamer conformations of ligand-proximal amino acids. These conformational changes imparted a ligand-specific volume to the binding pocket, from 490 Angstrom(3) in the metribolone complex to 520 Angstrom(3) in the norethindrone complex, 565 Angstrom(3) in the progesterone complex, and 730 Angstrom(3) in the mometasone furoate complex. Despite these marked alterations in binding pocket volume, critical interactions essential for establishment of an active AF2 conformation were maintained.This publication has 12 references indexed in Scilit:
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator RecognitionCell, 2002
- Editorial BoardAmerican Journal of Obstetrics and Gynecology, 2001
- Current perspectives on oral contraceptive useAmerican Journal of Obstetrics and Gynecology, 2001
- Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapyAmerican Journal of Obstetrics and Gynecology, 2001
- Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen ReceptorJournal of Biological Chemistry, 2000
- Atomic structure of progesterone complexed with its receptorNature, 1998
- [21] Data collection strategyPublished by Elsevier ,1997
- Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the ReceptorScience, 1989
- Interconversion of Adrenal Cortical Side Chains. The Transformation of Cortisone and Hydrocortisone to CorticosteroneJournal of the American Chemical Society, 1954
- PROGESTATIONAL ACTIVITY OF ORALLY ADMINISTERED 17α-ETHINYL-19-NORTESTOSTERONEEndocrinology, 1954